Krystal Biotech (KRYS) Net Cash Flow Growth (1y) (2017 - 2026)
Krystal Biotech (KRYS) Net Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | Krystal Biotech | 9.88 Bn | 9.06 Bn | 110.08 Mn | 117.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117.48% |
| Dec 31, 2025 | 466.00% |
| Sep 30, 2025 | 40.11% |
| Jun 30, 2025 | 441.54% |
| Mar 31, 2025 | -7,486.15% |
| Dec 31, 2024 | -92.97% |
| Sep 30, 2024 | -71.35% |
| Jun 30, 2024 | -109.53% |
| Mar 31, 2024 | 102.32% |
| Dec 31, 2023 | 39.62% |
| Sep 30, 2023 | 401.30% |
| Jun 30, 2023 | 367.13% |
| Mar 31, 2023 | 70.64% |
| Dec 31, 2022 | -144.79% |
| Sep 30, 2022 | 24.71% |
| Jun 30, 2022 | 30.37% |
| Mar 31, 2022 | -153.73% |
| Dec 31, 2021 | 487.46% |
| Sep 30, 2021 | -360.98% |
| Jun 30, 2021 | -165.18% |